PMVP
Healthcare BiotechnologyPMV Pharmaceuticals, Inc.
$1.78
-0.01 -0.56% today
Price History
Not enough data
Key Stats
Market Cap
134.41M
Avg Volume
629,501
EPS
-$1.42
52W High
$1.91
52W Low
$1.02
Div. Yield
0.0%
Analyst Ratings
Buy0
Str Buy
6
Buy
0
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
-1.84
P/B Ratio
1.33
EV/EBITDA
-0.19
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(70.9%)
Return on Assets
(42.4%)
Liquidity & Leverage
Current Ratio
7.70
Quick Ratio
7.52
Debt / Equity
0.00
Total Cash
79.43M
Total Debt
217,000
About
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
www.pmvpharma.com